multicenter experience evaluating chronic total occlusion crossing with the Wildcat catheter (the CONNECT study)


A multicenter experience evaluating chronic total occlusion crossing with the Wildcat catheter (the CONNECT study)


Pigott JP, for the Connect Trial Investigators (Jobst Vascular Inst, Toledo, OH; et al) J Vasc Surg 56:1615-1621, 2012§



M.T. Watkins, MD



Evidence Ranking


B



Expert Rating


1



Abstract




Methods


Between August 2010 and April 2011, patients with peripheral arterial disease due to a femoropopliteal CTO >1 cm and ≤35 cm were evaluated for study enrollment at 15 U.S. sites. During treatment, the physician initially attempted to cross the CTO using conventional guidewires per protocol; if the guidewire successfully crossed, the patient was considered a screen failure and the Wildcat was not deployed. At 30 days, patients were reevaluated. The primary efficacy end point was successful crossing of the Wildcat into the distal true lumen as confirmed by angiography. Primary safety end points included no in-hospital or 30-day major adverse events, no clinically significant perforation or embolization, and no grade C or greater dissection. Additional data collected included lesion length, degree of calcification, and location.

Stay updated, free articles. Join our Telegram channel

Apr 3, 2017 | Posted by in CARDIOLOGY | Comments Off on multicenter experience evaluating chronic total occlusion crossing with the Wildcat catheter (the CONNECT study)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access